154 related articles for article (PubMed ID: 37439915)
1. The Importance of the Individual in PrEP Uptake: Multilevel Correlates of PrEP Uptake Among Adolescent Girls and Young Women in Tshwane, South Africa.
Bonner CP; Minnis AM; Ndirangu JW; Browne FA; Speizer I; Nyblade L; Ahmed K; Wechsberg WM
AIDS Behav; 2023 Dec; 27(12):4124-4130. PubMed ID: 37439915
[TBL] [Abstract][Full Text] [Related]
2. Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa.
Bonner CP; Browne FA; Carney T; Shangase N; Ndirangu JW; Myers B; Wechsberg WM
S Afr Med J; 2022 Apr; 112(5):341-346. PubMed ID: 35587247
[TBL] [Abstract][Full Text] [Related]
3. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
[TBL] [Abstract][Full Text] [Related]
4. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
5. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
[TBL] [Abstract][Full Text] [Related]
6. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
[TBL] [Abstract][Full Text] [Related]
8. Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.
Medina-Marino A; Bezuidenhout D; Ngwepe P; Bezuidenhout C; Facente SN; Mabandla S; Hosek S; Little F; Celum CL; Bekker LG
J Int AIDS Soc; 2022 Jul; 25(7):e25968. PubMed ID: 35872602
[TBL] [Abstract][Full Text] [Related]
9. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
[TBL] [Abstract][Full Text] [Related]
10. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
[TBL] [Abstract][Full Text] [Related]
11. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
[TBL] [Abstract][Full Text] [Related]
12. The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa.
Wechsberg WM; Browne FA; Ndirangu J; Bonner CP; Minnis AM; Nyblade L; Speizer IS; Howard BN; Myers B; Ahmed K
BMC Public Health; 2020 Sep; 20(1):1403. PubMed ID: 32933510
[TBL] [Abstract][Full Text] [Related]
13. An individually randomized controlled trial of a mother-daughter HIV/STI prevention program for adolescent girls and young women in South Africa: IMARA-SA study protocol.
Donenberg GR; Atujuna M; Merrill KG; Emerson E; Ndwayana S; Blachman-Demner D; Bekker LG
BMC Public Health; 2021 Sep; 21(1):1708. PubMed ID: 34544403
[TBL] [Abstract][Full Text] [Related]
14. Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa.
Bergh K; Toska E; Duby Z; Govindasamy D; Mathews C; Reddy T; Jonas K
AIDS Behav; 2024 Apr; 28(4):1137-1151. PubMed ID: 37462890
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing adolescent girls and young women's uptake of community-based PrEP services following home-based HIV testing in Eastern Cape, South Africa: a qualitative study.
Mudzingwa EK; de Vos L; Atujuna M; Fynn L; Mugore M; Hosek S; Celum C; Bekker LG; Daniels J; Medina-Marino A
AIDS Behav; 2022 Nov; 26(11):3726-3739. PubMed ID: 35653046
[TBL] [Abstract][Full Text] [Related]
16. The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa.
Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Edwards JK; Gill K; Morton JF; van der Straten A; Celum C; Bekker LG
AIDS Behav; 2022 Apr; 26(4):1007-1016. PubMed ID: 34478015
[TBL] [Abstract][Full Text] [Related]
17. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial.
Munthali RJ; Stangl AL; Baron D; Barré I; Harvey S; Ramskin L; Colombini M; Naicker N; Kapiga S; Delany-Moretlwe S;
AIDS Behav; 2022 Dec; 26(12):3950-3962. PubMed ID: 35776254
[TBL] [Abstract][Full Text] [Related]
19. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
[TBL] [Abstract][Full Text] [Related]
20. A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial.
Celum C; Seidman D; Travill D; Dehlendorf C; Gumede S; Zewdie K; Wilson W; Morton JF; Baeten JM; Donnell D; Delany-Moretlwe S
J Int AIDS Soc; 2023 Aug; 26(8):e26154. PubMed ID: 37634942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
